1st Quarter - Report

THE MCMANUS GROUP for GENENTECH

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Follow-on biologics provisions in P.L. 111-148, "Patient Protection and Affordable Care Act."

Foreign entity interest: 100% ownership by Roche Holding, Ltd., 4070 Basel, Switzerland

LobbyistCovered position, as disclosed
JOHN MCMANUS —
NICK SHIPLEY Legislative Director, Rep. Jay Inslee

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Opposition to Medicare rebates in P.L. 111-148, "Patient Protection and Affordable Care Act." Independent Payment Advisory Board provisions in P.L. 111-148, "Patient Protection and Affordable Care Act" and P.L. 111-152, "Reconciliation Act of 2010."

Foreign entity interest: 100% ownership by Roche Holding, Ltd., 4070 Basel, Switzerland

LobbyistCovered position, as disclosed
JOHN MCMANUS —
NICK SHIPLEY Legislative Director, Rep. Jay Inslee

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.